Frédéric Lamoth

12.5k total citations · 1 hit paper
127 papers, 4.5k citations indexed

About

Frédéric Lamoth is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Frédéric Lamoth has authored 127 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Infectious Diseases, 74 papers in Epidemiology and 19 papers in Pharmacology. Recurrent topics in Frédéric Lamoth's work include Antifungal resistance and susceptibility (86 papers), Fungal Infections and Studies (57 papers) and Pneumocystis jirovecii pneumonia detection and treatment (23 papers). Frédéric Lamoth is often cited by papers focused on Antifungal resistance and susceptibility (86 papers), Fungal Infections and Studies (57 papers) and Pneumocystis jirovecii pneumonia detection and treatment (23 papers). Frédéric Lamoth collaborates with scholars based in Switzerland, United States and France. Frédéric Lamoth's co-authors include Thierry Calandra, William J. Steinbach, Praveen R. Juvvadi, Barbara D. Alexander, Oscar Marchetti, Dimitrios P. Kontoyiannis, Elizabeth L. Berkow, Shawn R. Lockhart, Gilbert Greub and Alix T. Coste and has published in prestigious journals such as Nature Communications, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Frédéric Lamoth

122 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Changes in the epidemiological landscape of invasive candidiasis

2017 390 citations Frédéric Lamoth, Thierry Calandra et al. Journal of Antimicrobial Chemotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frédéric Lamoth Switzerland	39	3.3k	2.7k	642	616	408	127	4.5k
Ronen Ben‐Ami Israel	36	2.8k 0.9×	2.6k 1.0×	620 1.0×	492 0.8×	235 0.6×	158	5.4k
Francesco Barchiesi Italy	41	3.7k 1.1×	3.0k 1.1×	900 1.4×	456 0.7×	558 1.4×	160	5.6k
Elizabeth L. Berkow United States	30	4.4k 1.3×	3.4k 1.3×	709 1.1×	424 0.7×	494 1.2×	53	5.3k
Javier Pemán Spain	41	5.2k 1.6×	4.0k 1.5×	695 1.1×	481 0.8×	721 1.8×	248	6.3k
Jesús Guinea Spain	41	4.9k 1.5×	3.9k 1.4×	555 0.9×	412 0.7×	780 1.9×	204	5.9k
L. Boyken United States	40	3.7k 1.1×	2.9k 1.1×	293 0.5×	381 0.6×	401 1.0×	65	4.1k
Vidmantas Petraitis United States	34	3.3k 1.0×	2.5k 0.9×	332 0.5×	624 1.0×	323 0.8×	110	3.9k
Koichi Izumikawa Japan	35	2.4k 0.7×	2.5k 0.9×	803 1.3×	412 0.7×	154 0.4×	353	4.8k
Rūta Petraitienė United States	36	3.4k 1.0×	2.7k 1.0×	292 0.5×	630 1.0×	357 0.9×	108	4.1k
Alessandro C. Pasqualotto Brazil	39	3.5k 1.1×	2.8k 1.0×	514 0.8×	357 0.6×	696 1.7×	167	5.0k

Countries citing papers authored by Frédéric Lamoth

Since Specialization

Citations

This map shows the geographic impact of Frédéric Lamoth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Lamoth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Lamoth more than expected).

Fields of papers citing papers by Frédéric Lamoth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Lamoth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Lamoth. The network helps show where Frédéric Lamoth may publish in the future.

Co-authorship network of co-authors of Frédéric Lamoth

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Lamoth. A scholar is included among the top collaborators of Frédéric Lamoth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Lamoth. Frédéric Lamoth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Douglas, Abby, Frédéric Lamoth, T.M. John, et al.. (2025). American Society of Transplantation and Cellular Therapy Series: #8-Management and Prevention of Non-Aspergillus Molds in Hematopoietic Cell Transplantation Recipients. Transplantation and Cellular Therapy. 31(4). 194–223.

Widanage, Malitha C. Dickwella, Jayasubba Reddy Yarava, Faith J. Scott, et al.. (2025). Distinct echinocandin responses of Candida albicans and Candida auris cell walls revealed by solid-state NMR. Nature Communications. 16(1). 6295–6295. 8 indexed citations

Pagano, Livio, Georg Maschmeyer, Frédéric Lamoth, et al.. (2025). Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL). Leukemia. 39(7). 1547–1557. 6 indexed citations

Grass, Fabian, Florian Desgranges, Antonios Kritikos, et al.. (2024). Antibacterial and antifungal drug concentrations in intra-abdominal abscesses: a prospective clinical study. Antimicrobial Agents and Chemotherapy. 69(1). e0117824–e0117824.

Stavropoulou, Elisavet, et al.. (2024). Antifungal Treatment Duration in Hematology Patients With Invasive Mold Infections: A Real-life Update. Open Forum Infectious Diseases. 11(5). ofae201–ofae201. 2 indexed citations

Lass‐Flörl, Cornelia, et al.. (2024). Clinicopathologic conference: Bloodstream infection in an allogeneic hamatopoietic cell transplant: Thinking beyond the usual. Transplant Infectious Disease. 26(4). e14273–e14273.

Coste, Alix T., et al.. (2024). Upc2-mediated mechanisms of azole resistance in Candida auris. Microbiology Spectrum. 12(2). e0352623–e0352623. 17 indexed citations

Haefliger, David, Catia Marzolini, Frédéric Lamoth, et al.. (2023). Clinically relevant bidirectional drug‐drug interaction between midostaurin and voriconazole. British Journal of Clinical Pharmacology. 89(7). 2304–2308. 1 indexed citations

Danion, François, Cléa Melenotte, Frédéric Lamoth, et al.. (2023). What Is New in Pulmonary Mucormycosis?. Journal of Fungi. 9(3). 307–307. 18 indexed citations

10.

Lamoth, Frédéric, et al.. (2023). Lung and sinus fungal infection imaging in immunocompromised patients. Clinical Microbiology and Infection. 30(3). 296–305. 4 indexed citations

11.

Lamoth, Frédéric. (2022). Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians. PubMed Central. 10 indexed citations

12.

Tschopp, Jonathan, Jean Yannis Perentes, Catherine Beigelman‐Aubry, et al.. (2021). Invasive Hormographiella aspergillata infection in patients with acute myeloid leukemia: Report of two cases successfully treated and review of the literature. Medical Mycology Case Reports. 32. 68–72. 4 indexed citations

13.

Goldenberger, Daniel, Patrick R. Wright, Stefan Zimmerli, et al.. (2021). Distribution of Aspergillus Species and Prevalence of Azole Resistance in Respiratory Samples From Swiss Tertiary Care Hospitals. Open Forum Infectious Diseases. 9(2). ofab638–ofab638. 13 indexed citations

14.

Meylan, Sylvain, Urania Dafni, Frédéric Lamoth, et al.. (2021). SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study. BMJ Open. 11(7). e049232–e049232. 8 indexed citations

15.

Kritikos, Antonios, Philippe M. Hauser, Malcolm Guiver, et al.. (2020). Ability of quantitative PCR to discriminate Pneumocystis jirovecii pneumonia from colonization. Journal of Medical Microbiology. 69(5). 705–711. 30 indexed citations

16.

Alexander, Barbara D., Frédéric Lamoth, Claus Peter Heußel, et al.. (2020). Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Imaging Working Group for the Revision and Update of the Consensus Definitions of Fungal Disease from the EORTC/MSGERC. Clinical Infectious Diseases. 72(Supplement_2). S79–S88. 60 indexed citations

17.

Mària, Cristina García de la, Antony Croxatto, Stefano Giulieri, et al.. (2019). Successful treatment with daptomycin and ceftaroline of MDR Staphylococcus aureus native valve endocarditis: a case report. Journal of Antimicrobial Chemotherapy. 74(9). 2626–2630. 12 indexed citations

18.

Lamoth, Frédéric, Lauro Damonti, & Barbara D. Alexander. (2016). Role of Antifungal Susceptibility Testing in Non-Aspergillus Invasive Mold Infections. Journal of Clinical Microbiology. 54(6). 1638–1640. 31 indexed citations

19.

Steinbach, William J., Frédéric Lamoth, & Praveen R. Juvvadi. (2015). Potential Microbiological Effects of Higher Dosing of Echinocandins. Clinical Infectious Diseases. 61(suppl_6). S669–S677. 35 indexed citations

20.

Wójtowicz, Agnieszka, Frédéric Tissot, Frédéric Lamoth, et al.. (2014). Polymorphisms in Tumor Necrosis Factor-α Increase Susceptibility to Intra-Abdominal Candida Infection in High-Risk Surgical ICU Patients*. Critical Care Medicine. 42(4). e304–e308. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact